+13.1%
GSK vs REPL
+125.1%
-112.0%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | REPL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +0.2% | +4.8% | +5.0% |
| 7D | +4.9% | +28.8% | -23.9% | +5.2% |
| 30D | +9.9% | +57.3% | -47.5% | +10.5% |
| 3M | +0.2% | +73.6% | -73.4% | +0.8% |
| 6M | +2.3% | +582.8% | -580.5% | +3.8% |
| YTD | +7.1% | +112.9% | -105.8% | +12.2% |
| 1Y | +13.1% | +130.7% | -117.5% | +15.5% |
| All | +13.1% | +125.1% | -112.0% | +15.5% |
Cumulative growth
Daily Returns
Daily percentage return beside REPL.
Daily Out/Under-Performance
Portfolio return minus REPL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × REPL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded REPL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling